These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3363755

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
    Shupak A, Gordon CR, Spitzer O, Mendelowitz N, Melamed Y.
    Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
    Attias J, Gordon C, Ribak J, Binah O, Rolnick A.
    Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z, Shahal B, Shupak A, Spitzer O, Gonen A, Beiran I, Lavon H, Eynan M, Dachir S, Levy A.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [Abstract] [Full Text] [Related]

  • 9. Transdermal scopolamine: human performance and side effects.
    Gordon C, Binah O, Attias J, Rolnick A.
    Aviat Space Environ Med; 1986 Mar; 57(3):236-40. PubMed ID: 3964152
    [Abstract] [Full Text] [Related]

  • 10. Side effects of antimotion sickness drugs.
    Wood CD, Manno JE, Manno BR, Redetzki HM, Wood M, Vekovius WA.
    Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
    Harnett MJ, O'Rourke N, Walsh M, Carabuena JM, Segal S.
    Anesth Analg; 2007 Sep; 105(3):764-9. PubMed ID: 17717237
    [Abstract] [Full Text] [Related]

  • 14. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
    Graybiel A, Cramer DB, Wood CD.
    Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A.
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.